Research Article

Psychometric Properties of the Apathy Scale in Advanced Parkinson’s Disease

Table 1

Descriptive statistics of other measures in the study.

MeasuresMeanSDMinMax

Beck Anxiety Inventory19.779.24041
Beck Depression Inventory-II18.119.34146
Schwab and England Scale (“on state”)69.8423.7710100
Non-Motor Symptoms Scale-total score83.0532.0729167
 Cardiovascular (including falls)2.413.53014
 Sleep/fatigue16.877.63040
 Mood/cognition15.6913.93056
 Perceptual problems/hallucinations3.085.53025
 Attention/memory5.806.11024
 Gastrointestinal tract7.446.23024
 Urinary12.449.59036
 Sexual function7.808.16024
 Miscellaneous11.518.68036
PDQ-39 (summary index)46.1313.8110.9085.90
 Mobility66.8822.312.50100.00
 Activities of daily living54.6524.484.1795.83
 Emotional well-being47.9221.704.17100.00
 Stigma20.1022.61093.75
 Social support18.8924.490100.00
 Cognitions36.3520.89093.75
 Communication31.8124.670100.00
 Bodily discomfort45.6920.730100.00
Parkinson Fatigue Scale (PFS-16)58.7112.4318.0078.00
UPDRS-motor examination30.0514.06458
UPDRS-complications8.622.87315
Zarit Burden Interview25.3013.47464
Levodopa equivalent daily dose (mg)1455.98456.00478.003110.00

Max, maximum; Min, minimum; PDQ-39, Parkinson’s Disease Questionnaire-39 Items; SD, standard deviation; UPDRS, Unified Parkinson’s Disease Rating Scale.